Profile
Alexander R.
Lussow worked as Head of Business Development at SangStat Medical Corp.
He then worked as Chief Business Officer and VP of Business Development at Gryphon Therapeutics, Inc. Later, he worked as SVP of Business Development and Commercial Operations at QLT, Inc. Lastly, he worked as a Professor at The University of North Carolina at Charlotte.
Lussow received his undergraduate degree from McGill University and his doctorate from the University of Geneva.
Former positions of Alexander R. Lussow
| Companies | Position | End |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 2014-05-30 |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
| SangStat Medical Corp. | Corporate Officer/Principal | - |
Gryphon Therapeutics, Inc.
 Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gryphon Therapeutics, Inc. develops and produces protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics was founded in 1993 and is headquartered in South San Francisco, CA | Corporate Officer/Principal | - |
Training of Alexander R. Lussow
| McGill University | Undergraduate Degree |
| University of Geneva | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Gryphon Therapeutics, Inc.
Gryphon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gryphon Therapeutics, Inc. develops and produces protein therapeutics. Its products combine chemically synthesized protein backbones with polyethylene glycols, such as molecules to create potent medications. Gryphon Therapeutics was founded in 1993 and is headquartered in South San Francisco, CA | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
| SangStat Medical Corp. | Health Technology |
- Stock Market
- Insiders
- Alexander R. Lussow
